Publicaciones en colaboración con investigadores/as de Hospital General Universitario de Valencia (15)

2023

  1. Benefits of dapagliflozin in the whole spectrum of heart failure in clinical practice: the RICA registry

    Future cardiology, Vol. 19, Núm. 6, pp. 323-332

  2. Prognostic Impact of the UMIPIC Program in the Follow Up in Patients with Heart Failure and Cardiorenal Syndrome

    Journal of Clinical Medicine, Vol. 12, Núm. 23

  3. Prognostic utility of pulse pressure in patients with heart failure with preserved ejection fraction: RICA Registry

    Revista Clinica Espanola, Vol. 223, Núm. 4, pp. 231-239

2022

  1. Benefits of a comprehensive care model in patients with heart failure and preserved ejection fraction: The UMIPIC program

    Revista Clinica Espanola, Vol. 222, Núm. 6, pp. 339-347

  2. Clinical Characteristics and Prognostic Relevance of Different Types of Caregivers for Elderly Patients with Acute Heart Failure—Analysis from the RICA Registry

    Journal of Clinical Medicine, Vol. 11, Núm. 12

2021

  1. Consensus on basic conduct during the hospital admission of patients with acute heart failure

    Revista Clinica Espanola, Vol. 221, Núm. 5, pp. 283-296

  2. Vacunas COVID-19 y procedimientos intervencionistas en dolor

    MPJ Multidisciplinary Pain Journal, Núm. 1

2019

  1. Spanish Catheter Ablation Registry. 18th Official Report of the Spanish Society of Cardiology Working Group on Electrophysiology and Arrhythmias (2018)

    Revista Espanola de Cardiologia, Vol. 72, Núm. 12, pp. 1031-1042

2018

  1. Short- and Long-Term Prognostic Relevance of Cardiogenic Shock in Takotsubo Syndrome: Results From the RETAKO Registry

    JACC: Heart Failure, Vol. 6, Núm. 11, pp. 928-936

  2. Spanish Catheter Ablation Registry. 17th Official Report of the Spanish Society of Cardiology Working Group on Electrophysiology and Arrhythmias (2017)

    Revista Espanola de Cardiologia, Vol. 71, Núm. 11, pp. 941-951

2017

  1. Influence of renal dysfunction phenotype on mortality in decompensated heart failure with preserved and mid-range ejection fraction

    International Journal of Cardiology, Vol. 243, pp. 332-339

2016

  1. Análisis de coste efectividad de fesoterodina comparado con mirabegron en el marco de tratamiento de primera línea para vejiga hiperactiva con incontinencia urinaria de urgencia, desde la perspectiva del Sistema Nacional de Salud español

    Actas Urologicas Espanolas, Vol. 40, Núm. 8, pp. 513-522

2008

  1. Levobupivacaine plus fentanyl versus racemic bupivacaine plus fentanyl in epidural anaesthesia for lower limb surgery

    Minerva Anestesiologica, Vol. 74, Núm. 7-8, pp. 381-391

2007

  1. Unidades coronarias de cuidados intermedios: Base racional, infraestructura, equipamiento e indicaciones de ingreso

    Revista Espanola de Cardiologia, Vol. 60, Núm. 4, pp. 404-414

2002

  1. New data on secondary prevention of myocardial infarction in Spain. Results of the PREVESE II Study

    Revista Espanola de Cardiologia, Vol. 55, Núm. 8, pp. 801-809